Kirkland & Ellis Represents Madison Dearborn, Ikaria in $2.3B Sale to Mallinckrodt

Kirkland & Ellis LLP represented Madison Dearborn Partners and Ikaria, Inc., a privately held critical care company, which today announced that it has reached a definitive agreement with Mallinckrodt plc under which a subsidiary of Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion. Mallinckrodt (NYSE: MNK), is a leading global specialty biopharmaceutical company. Subject to customary closing conditions, the parties expect the transaction to be completed early in the second calendar quarter of 2015. For more information on the transaction, please click here.

The Kirkland team included corporate partners Sanford Perl, Mark Fennell and Matthew O’Brien and associates Matthew Mauney and Christine Bedi, capital markets partner Dennis Myers and debt finance partners Michael Wright and Maureen Dixon.